Report Overview
Endostatin is a naturally occurring, 20-kDa C-terminal fragment derived from type XVIII collagen. Human monomeric endostatin is a globular protein containing two disulfide bonds: Cys162 302 and Cys264 294.
This report provides a deep insight into the global Recombinant Human Endostatin market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
www.reallygreatsite.com
Market Share
The global Recombinant Human Endostatin market size was estimated at USD 130 million in 2023 and is projected to reach USD 259.87 million by 2032, exhibiting a CAGR of 8.00% during the forecast period.
NorthAmerica Recombinant Human Endostatin market size was estimated at USD 38.68 million in 2023, at a CAGR of 6.86% during the forecast period of 2025 through 2032.
Market Segmentation
• Purity:95%
• Others
By Application
• Medical Care
• Scientific Research
• Others
Geographic Segmentation
•North America: USA, Canada, Mexico
•Europe: Germany, UK, France, Russia, Italy, Rest of Europe
•Asia-Pacific: China, Japan, South Korea, India, SoutheastAsia, Rest ofAsia-Pacific
•South America: Brazil, Argentina, Colombia, Rest of SouthAmerica
•Middle East and Africa: Saudi Arabia, UAE, Egypt, Nigeria, SouthAfrica, Rest of MEA
